117 related articles for article (PubMed ID: 23827702)
1. Oncogenic miRNAs and the perils of losing control of a stem cell's epigenetic identity.
Dalerba P; Clarke MF
Cell Stem Cell; 2013 Jul; 13(1):5-6. PubMed ID: 23827702
[TBL] [Abstract][Full Text] [Related]
2. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
Song SJ; Ito K; Ala U; Kats L; Webster K; Sun SM; Jongen-Lavrencic M; Manova-Todorova K; Teruya-Feldstein J; Avigan DE; Delwel R; Pandolfi PP
Cell Stem Cell; 2013 Jul; 13(1):87-101. PubMed ID: 23827711
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.
Song SJ; Poliseno L; Song MS; Ala U; Webster K; Ng C; Beringer G; Brikbak NJ; Yuan X; Cantley LC; Richardson AL; Pandolfi PP
Cell; 2013 Jul; 154(2):311-324. PubMed ID: 23830207
[TBL] [Abstract][Full Text] [Related]
4. miR-22 in tumorigenesis.
Song SJ; Pandolfi PP
Cell Cycle; 2014; 13(1):11-2. PubMed ID: 24231768
[No Abstract] [Full Text] [Related]
5. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
[TBL] [Abstract][Full Text] [Related]
6. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
8. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
Wu KJ; Yang MH
Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and parallel stem cell lives.
Dirks PB
Cell; 2009 Aug; 138(3):423-4. PubMed ID: 19665962
[TBL] [Abstract][Full Text] [Related]
12. Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo.
Chen JH; Huang WC; Bamodu OA; Chang PM; Chao TY; Huang TH
BMC Cancer; 2019 Jun; 19(1):634. PubMed ID: 31248373
[TBL] [Abstract][Full Text] [Related]
13. miR-214 inhibits epithelial-mesenchymal transition of breast cancer cells via downregulation of RNF8.
Min L; Liu C; Kuang J; Wu X; Zhu L
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):791-798. PubMed ID: 31294443
[TBL] [Abstract][Full Text] [Related]
14. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
15. [The human hematopoietic stem cell, normal and leukemic].
Gabbianelli M; Valtieri M; Peschle C
Haematologica; 1991 Jun; 76 Suppl 3():293-302. PubMed ID: 1752525
[No Abstract] [Full Text] [Related]
16. EMT in breast cancer stem cell generation.
Ansieau S
Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
[TBL] [Abstract][Full Text] [Related]
17. The involvement of microRNAs in malignant transformation.
Rutnam ZJ; Yang BB
Histol Histopathol; 2012 Oct; 27(10):1263-70. PubMed ID: 22936445
[TBL] [Abstract][Full Text] [Related]
18. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
[TBL] [Abstract][Full Text] [Related]
19. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and breast cancer stem cells: Potential role in breast cancer therapy.
Vahidian F; Mohammadi H; Ali-Hasanzadeh M; Derakhshani A; Mostaan M; Hemmatzadeh M; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3294-3306. PubMed ID: 30362508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
